Last update 01 Nov 2024
ReqMed Co., Ltd.

ReqMed Co., Ltd.

Holding Company|
1998|
Tokyo-to, Japan
|
10-50
|
www.reqmed.co.jp

Overview

Tags

Congenital Disorders
Skin and Musculoskeletal Diseases
Nervous System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease2
Nervous System Diseases2
Infectious Diseases1
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
RT(Viral reverse transcriptase)1

Related

3
Drugs associated with ReqMed Co., Ltd.
Betaine
Target-
Mechanism-
Active Org.
SERB SA [+7]
Originator Org.
Orphan Europe SARLOrphan Europe SARL
Active Indication
Homocystinuria [+1]
Inactive Indication
Refsum Disease, Infantile [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
AU
First Approval Date01 Oct 1996
Pentosan Polysulfate Sodium
Target
RT
Mechanism
RT inhibitors [+1]
Active Org.
Paradigm Biopharmaceuticals Ltd.Paradigm Biopharmaceuticals Ltd. [+8]
Originator Org.
IVAX LLCIVAX LLC
Active Indication
Cystitis, Interstitial [+13]
Inactive Indication
Atherosclerosis [+3]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date26 Sep 1996
RM-1319
Target-
Mechanism-
Active Org.-
Originator Org.
ReqMed Co., Ltd.ReqMed Co., Ltd.
Active Indication-
Inactive Indication
Metabolism, Inborn Errors
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
6
Clinical Trials associated with ReqMed Co., Ltd.
JPRN-UMIN000041118 / CompletedPhase 3
Phase III study combined with post-marketing clinical study of RM1319 in patients with inborn errors of bile acid metabolism, including children - Phase III study combined with post-marketing clinical study of RM1319 in patients with inborn errors of bile acid metabolism, including children
JPRN-jRCT2080223060 / CompletedPhase 1/2
Safety study of NaPPS in pediatric patients with mucopolysaccharidosis type VI
JPRN-JapicCTI-163114 / CompletedPhase 1/2
Safety study of NaPPS in pediatric patients with mucopolysaccharidosis type VI
100 Clinical Results associated with ReqMed Co., Ltd.
Login to view more data
0 Patents (Medical) associated with ReqMed Co., Ltd.
Login to view more data
3
Literatures (Medical) associated with ReqMed Co., Ltd.
Seibutsu Kogaku Kaishi
New encounter especially when things were bad
Seibutsu Kogaku Kaishi
Come over Inter-college, Bioseries
Seibutsu Kogaku Kaishi
Carrer path. Novartis/biocamp: dream, challenge and presure
100 Deals associated with ReqMed Co., Ltd.
Login to view more data
100 Translational Medicine associated with ReqMed Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
1
Approved
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Betaine
Homocystinuria
More
Approved
Pentosan Polysulfate Sodium
 ( RT )		Osteoarthritis, Knee
More
Phase 2
RM-1319
Metabolism, Inborn Errors
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free